Xilio Therapeutics (United States)

Dying in the year after surviving: a perspective on elevated all-cause mortality among opioid overdose survivors

It has been reported that opioid overdose survivors who had a prior non-fatal opioid overdose have a substantially elevated one-year all-cause mortality compared to first-time overdose survivors. The objective of this Perspective was to construct a framework for assessing the obs...